Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study
Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection
Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs
HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial
START sub-studies show no differences in lung or neurocognitive function with early or later treatment
Community-based drug projects provide an alternative to compulsory detention in Asia
START sub-study shows more bone loss with earlier HIV treatment
London clinic survey shows impact of chemsex on condom and PEP use
Risk of heart attack rises with length of HIV infection, regardless of age
